Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: IRELAND

Sector: Medical Devices

Medtronic, PLC develops therapeutic and diagnostic medical products. The Company"s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic"s products are sold worldwide.
Website: medtronic.com


  • Pretty weak financial results growth rate 5.4% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (2.4%)
  • Dividend yield for the last twelve months 2.8%
  • Free cash flow yield -3.7% (LTM)
  • Share price is 43.3% higher than minimum and 5.6% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (17.4x vs 16.9x)
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $3.1 mln (-0.002% of cap.)

Key Financials (Download financials)

Ticker: MDT
Share price, USD:  (-1.4%)99.49
year average price 92.29  


year start price 92.81 2025-02-16

min close price 80.68 2025-05-23

max close price 105.35 2025-11-25

current price 99.49 2026-02-15
Common stocks: 1 328 710 044

Dividend Yield:  2.8%
FCF Yield LTM: -3.7%
EV / LTM EBITDA: 17.4x
EV / EBITDA annualized: 16.9x
Last revenue growth (y/y):  +6.6%
Last growth of EBITDA (y/y):  +4.2%
Historical revenue growth:  +4.1%
Historical growth of EBITDA:  +0.7%
EV / Sales: 4.6x
Margin (EBITDA LTM / Revenue): 26.5%

Target EV / EBITDA (hist percentile): 16.9x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 132 193
Net Debt ($m): 27 818
EV (Enterprise Value): 160 011
EBITDA LTM (млн $): 9 197
EV / LTM EBITDA: 17.4x
Price to Book: 2.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-02-05businesswire.com

Applied Medical Prevails in Antitrust Jury Trial Against Medtronic

2026-02-05reuters.com

Medtronic owes $382 million to medical device rival in antitrust lawsuit, US jury says

2026-02-03prnewswire.com

Medtronic advances its innovation strategy with intent to acquire CathWorks

2026-02-02prnewswire.com

Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances

2026-01-30zacks.com

Why the Market Dipped But Medtronic (MDT) Gained Today

2026-01-23youtube.com

Final Trades: Capital One, Medtronic, Transocean and Caterpillar

2026-01-23prnewswire.com

Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation

2026-01-21seekingalpha.com

Medtronic: Don't Miss Out On This Dividend Aristocrat Now

2026-01-18fool.com

3 Reasons to Add This Medical Technology Stock to Your Portfolio in 2026

2025-12-29fool.com

Medtronic: A Strong Contender in the Medical Device Arena
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-10-24 2025-07-25 2025-04-30 2024-10-25 2024-07-26 2024-04-30 2024-01-26 2023-10-27 2023-07-28 2023-04-30 2023-01-27 2022-10-28 2022-04-30 2021-04-30
symbol MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-25 2025-08-26 2024-11-26 2024-08-27 2024-02-27 2023-11-30 2023-08-31 2023-03-01 2022-12-01
acceptedDate 2025-11-25 16:18:41 2025-08-26 17:26:56 2025-06-20 06:46:20 2024-11-26 16:16:06 2024-08-27 16:18:26 2024-06-20 16:16:51 2024-02-27 16:16:45 2023-11-30 16:16:21 2023-08-31 16:16:07 2023-06-22 16:32:12 2023-03-01 16:13:18 2022-12-01 16:17:57 2022-06-23 16:13:25 2021-06-25 16:51:46
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 8 961M 8 578M 33 537M 8 403M 7 915M 32 364M 8 089M 7 984M 7 702M 31 227M 7 727M 7 585M 31 686M 30 117M
costOfRevenue 3 556M 3 632M 11 632M 2 946M 3 203M 11 216M 2 782M 2 761M 2 628M 10 719M 2 689M 2 535M 10 145M 10 483M
grossProfit 5 405M 4 946M 21 905M 5 457M 4 712M 21 148M 5 307M 5 223M 5 074M 20 508M 5 038M 5 050M 21 541M 19 634M
grossProfitRatio 0.603 0.577 0.649 0.595 0.656 0.654 0.659 0.652 0.666
researchAndDevelopmentExpenses 754M 726M 2 732M 697M 676M 2 735M 695M 698M 668M 2 696M 688M 676M 2 746M 2 493M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 2 966M 2 806M 10 849M 2 757M 2 626M 10 736M 2 673M 2 686M 2 613M 10 415M 2 615M 2 617M 10 292M 10 148M
otherExpenses 0 -31M 2 369M 408M 583M 2 533M -88M 154M 76M 1 912M 306M 324M 2 751M 2 509M
operatingExpenses 3 720M 3 501M 15 950M 3 862M 3 885M 16 004M 3 368M 3 778M 3 711M 15 023M 3 609M 3 617M 15 789M 15 150M
costAndExpenses 7 276M 7 133M 27 582M 6 808M 6 637M 27 220M 6 150M 6 539M 6 339M 25 742M 6 298M 6 152M 25 934M 25 633M
interestIncome 0 33M 0 0 0 0 170M 148M 0 0 0 0 0 0
interestExpense 181M 176M 729M 209M 167M 719M 188M 180M 148M 636M 167M 118M 553M 925M
depreciationAndAmortization 589M 748M 2 861M 675M 662M 2 647M 649M 672M 672M 2 697M 867M 810M 2 707M 2 702M
ebitda 2 366M 2 225M 9 218M 2 443M 2 048M 8 203M 1 483M 2 270M 2 110M 8 697M 2 259M 2 214M 8 777M 7 522M
ebitdaratio 0.264 0.259 0.291 0.259 0.183 0.284 0.274 0.292 0.292
operatingIncome 1 685M 1 445M 5 955M 1 595M 1 278M 5 144M 1 483M 1 340M 1 268M 5 485M 1 392M 1 404M 5 752M 4 484M
operatingIncomeRatio 0.188 0.168 0.19 0.161 0.183 0.168 0.165 0.18 0.185
totalOtherIncomeExpensesNet -89M -143M -327M -36M -10M -307M -11M 49M -18M -121M -17M -9M -235M -589M
incomeBeforeTax 1 596M 1 302M 5 628M 1 559M 1 268M 4 837M 1 472M 1 313M 1 196M 5 364M 1 375M 1 395M 5 517M 3 895M
incomeBeforeTaxRatio 0.178 0.152 0.186 0.16 0.182 0.164 0.155 0.178 0.184
incomeTaxExpense 215M 255M 936M 281M 220M 1 133M 135M 402M 400M 1 580M 146M 959M 456M 265M
netIncome 1 374M 1 040M 4 662M 1 270M 1 042M 3 676M 1 322M 909M 791M 3 758M 1 222M 427M 5 039M 3 606M
netIncomeRatio 0.153 0.121 0.151 0.132 0.163 0.114 0.103 0.158 0.056
eps 1.07 0.81 3.63 0.99 0.81 2.77 0.99 0.68 0.59 2.83 0.92 0.32 3.75 2.68
epsdiluted 1.07 0.81 0.99 0.8 0.99 0.68 0.59 0.92 0.32
weightedAverageShsOut 1 282M 1 282M 1 286M 1 282M 1 293M 1 328M 1 330M 1 330M 1 331M 1 330M 1 330M 1 329M 1 342M 1 345M
weightedAverageShsOutDil 1 288M 1 287M 1 290M 1 287M 1 297M 1 330M 1 332M 1 332M 1 334M 1 333M 1 332M 1 332M 1 351M 1 354M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-06-20 2024-06-20 2023-06-22 2022-06-23 2021-06-25
fiscalYear 2025 2024 2023 2022 2021
netInterestIncome -729M -719M -636M -553M -925M
ebit 6 357M 5 556M 6 000M 6 070M 4 820M
nonOperatingIncomeExcludingInterest -402M -412M -515M -318M -336M
netIncomeFromContinuingOperations 4 691M 3 704M 3 784M 5 061M 3 630M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 -1 000 000 0 -1 000 000 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 4 662M 3 676M 3 758M 5 039M 3 606M
epsDiluted 3.61 2.76 2.82 3.73 2.66

Balance Sheet Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-10-24 2025-07-25 2025-04-30 2024-10-25 2024-07-26 2024-04-30 2024-01-26 2023-10-27 2023-07-28 2023-04-30 2023-01-27 2022-10-28 2022-04-30 2021-04-30
symbol MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-25 2025-08-26 2024-11-26 2024-08-27 2024-02-27 2023-11-30 2023-08-31 2023-03-01 2022-12-01
acceptedDate 2025-11-25 16:18:41 2025-08-26 17:26:56 2025-06-20 06:46:20 2024-11-26 16:16:06 2024-08-27 16:18:26 2024-06-20 16:16:51 2024-02-27 16:16:45 2023-11-30 16:16:21 2023-08-31 16:16:07 2023-06-22 16:32:12 2023-03-01 16:13:18 2022-12-01 16:17:57 2022-06-23 16:13:25 2021-06-25 16:51:46
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 1 282M 1 273M 2 218M 1 394M 1 311M 1 284M 1 623M 1 311M 1 339M 1 543M 4 521M 4 828M 3 714M 3 593M
shortTermInvestments 7 045M 6 848M 6 747M 6 595M 6 532M 6 721M 6 698M 6 423M 6 537M 6 416M 6 616M 6 602M 6 859M 7 224M
cashAndShortTermInvestments 8 327M 8 121M 8 965M 7 989M 7 843M 8 005M 8 321M 7 734M 7 876M 7 959M 11 137M 11 430M 10 573M 10 817M
netReceivables 6 389M 6 263M 6 515M 6 260M 6 011M 6 128M 5 968M 5 934M 5 806M 5 998M 5 887M 5 626M 5 551M 5 462M
inventory 6 156M -373M 5 476M 5 479M 5 414M 5 217M 5 726M 5 754M 5 668M 5 293M 5 375M 5 055M 4 616M 4 313M
otherCurrentAssets 3 124M 9 212M 2 858M 2 710M 2 679M 2 585M 2 498M 2 659M 2 519M 2 425M 2 965M 3 287M 2 319M 1 956M
totalCurrentAssets 23 996M 23 223M 23 814M 22 438M 21 947M 21 935M 22 513M 22 081M 21 869M 21 675M 25 364M 25 398M 23 059M 22 548M
propertyPlantEquipmentNet 7 164M -504M 6 837M 6 438M 6 282M 6 131M 5 838M 5 735M 5 665M 5 569M 5 437M 5 298M 5 413M 5 221M
goodwill 41 811M 42 007M 41 737M 41 161M 41 084M 40 986M 41 160M 40 821M 41 436M 41 425M 41 565M 40 417M 40 502M 41 961M
intangibleAssets 10 770M 11 223M 11 667M 12 423M 12 819M 13 225M 13 690M 14 060M 14 434M 14 844M 15 265M 15 655M 15 594M 17 740M
goodwillAndIntangibleAssets 52 581M 53 230M 53 404M 53 584M 53 903M 54 211M 54 850M 54 881M 55 870M 56 269M 56 830M 56 072M 56 096M 59 701M
longTermInvestments 0 0 0 0 1 672M 0 1 847M 1 752M 0 0 0 0 0 0
taxAssets 0 0 0 0 -1 672M 0 3 599M 3 428M 0 0 0 0 0 0
otherNonCurrentAssets 7 605M 15 023M 7 624M 7 582M 5 945M 7 704M 2 189M 2 210M 7 373M 7 436M 6 503M 6 474M 6 411M 5 612M
totalNonCurrentAssets 67 350M 67 749M 67 865M 67 604M 67 802M 68 046M 68 323M 68 006M 68 908M 69 274M 68 770M 67 844M 67 920M 70 534M
otherAssets 0 0 1 000 000 0 0 0 0 0 -1 000 000 -1 000 000 0 -1 000 000 2M 1 000 000
totalAssets 91 346M 90 972M 91 680M 90 042M 89 749M 89 981M 90 836M 90 087M 90 776M 90 948M 94 134M 93 241M 90 981M 93 083M
accountPayables 2 581M 2 555M 2 449M 2 376M 2 291M 2 410M 1 992M 2 174M 2 239M 2 662M 2 209M 2 198M 2 276M 2 106M
shortTermDebt 1 420M 2 430M 2 868M 3 719M 1 553M 1 086M 1 029M 1 339M 519M 13M 5 918M 5 864M 3 736M 2M
taxPayables 0 402M 0 947M 1 063M 1 330M 1 109M 1 088M 1 013M 840M 657M 651M 704M 435M
deferredRevenue 0 0 0 0 0 0 350M 6 145M 1 013M 0 0 0 0 0
otherCurrentLiabilities 5 934M 6 143M 2 515M 5 153M 5 380M 2 375M 6 422M 1 000 000 5 276M 1 948M 6 295M 6 403M 2 121M 2 482M
totalCurrentLiabilities 9 935M 11 530M 12 879M 12 195M 10 287M 10 789M 9 793M 9 659M 9 047M 9 051M 14 422M 14 465M 12 394M 8 509M
longTermDebt 27 680M 26 179M 25 590M 24 607M 26 312M 23 877M 24 097M 23 741M 24 463M 24 287M 22 210M 20 753M 20 316M 26 316M
deferredRevenueNonCurrent 0 0 0 0 0 0 97M 2 797M 3 499M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 386M 416M 403M 473M 496M 515M 615M 686M 687M 708M 747M 871M 884M 1 028M
otherNonCurrentLiabilities 4 488M 4 714M 4 500M 4 051M 4 494M 4 325M 4 239M 1 557M 1 714M 5 180M 5 137M 18 657M 4 609M 5 566M
totalNonCurrentLiabilities 32 554M 31 309M 30 545M 29 131M 31 302M 28 772M 29 048M 28 781M 30 363M 30 232M 28 094M 26 719M 25 865M 32 972M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 51M 58M 0 52M 61M 56M 56M 57M 64M 55M 55M 62M 71M
totalLiabilities 42 489M 42 839M 43 424M 41 326M 41 589M 39 561M 38 841M 38 440M 39 410M 39 283M 42 516M 41 184M 38 259M 41 481M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 0 -28M 0 0 0 0 0 0 0 0 0 0 0 0
retainedEarnings 32 070M 31 606M 31 476M 30 919M 30 547M 30 403M 30 661M 30 256M 30 265M 30 392M 30 117M 29 799M 30 250M 28 594M
accumulatedOtherComprehensiveIncomeLoss -4 275M -4 604M -4 284M -3 250M -3 410M -3 318M -3 459M -3 377M -3 674M -3 499M -3 189M -2 361M -2 265M -3 485M
othertotalStockholdersEquity 20 857M 20 919M 20 825M 20 810M 24 590M 24 581M 24 587M 24 513M 24 442M
totalStockholdersEquity 48 652M 47 893M 48 024M 48 494M 47 947M 50 214M 51 792M 51 460M 51 178M 51 483M 51 441M 51 880M 52 551M 51 428M
totalEquity 48 857M 48 133M 48 256M 48 716M 48 160M 50 420M 51 996M 51 647M 51 366M 51 665M 51 441M 51 880M 52 722M 51 602M
totalLiabilitiesAndStockholdersEquity 91 141M 90 972M 90 042M 89 749M 90 837M 90 087M 90 776M 94 134M 93 241M
minorityInterest 204M 240M 232M 222M 213M 206M 204M 187M 188M 182M 177M 177M 171M 174M
totalLiabilitiesAndTotalEquity 91 141M 90 972M 91 680M 90 042M 89 749M 89 981M 90 837M 90 087M 90 776M 90 948M 94 134M 93 241M 90 981M 93 083M
totalInvestments 7 045M 6 848M 6 747M 6 595M 8 204M 6 721M 8 545M 6 423M 6 537M 6 416M 6 616M 6 602M 6 859M 7 224M
totalDebt 29 100M 28 609M 28 516M 28 326M 27 865M 25 024M 25 182M 25 080M 24 982M 24 364M 28 128M 26 617M 24 114M 26 389M
netDebt 27 818M 27 336M 26 298M 26 932M 26 554M 23 740M 23 559M 23 769M 23 643M 22 821M 23 607M 21 789M 20 400M 22 796M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-06-20 2024-06-20 2023-06-22 2022-06-23 2021-06-25
fiscalYear 2025 2024 2023 2022 2021
accountsReceivables 6 515M 6 128M 5 998M 5 551M 5 462M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 0 0
totalPayables 3 807M 3 740M 3 502M 2 980M 2 541M
otherPayables 1 358M 1 330M 840M 704M 435M
accruedExpenses 3 683M 3 582M 3 581M 3 551M 3 475M
capitalLeaseObligationsCurrent 6M 6M 7M 6M 9M
capitalLeaseObligationsNonCurrent 52M 55M 57M 56M 62M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 20 833M 23 129M 24 590M 24 566M 26 319M
otherTotalStockholdersEquity -1 000 000 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-10-24 2025-07-25 2025-04-30 2024-10-25 2024-07-26 2024-04-30 2024-01-26 2023-10-27 2023-07-28 2023-04-30 2023-01-27 2022-10-28 2022-04-30 2021-04-30
symbol MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT MDT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-25 2025-08-26 2024-11-26 2024-08-27 2024-02-27 2023-11-30 2023-08-31 2023-03-01 2022-12-01
acceptedDate 2025-11-25 16:18:41 2025-08-26 17:26:56 2025-06-20 06:46:20 2024-11-26 16:16:06 2024-08-27 16:18:26 2024-06-20 16:16:51 2024-02-27 16:16:45 2023-11-30 16:16:21 2023-08-31 16:16:07 2023-06-22 16:32:12 2023-03-01 16:13:18 2022-12-01 16:17:57 2022-06-23 16:13:25 2021-06-25 16:51:46
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome 1 374M 1 047M 4 691M 1 278M 1 042M 3 676M 1 322M 911M 797M 3 784M 1 228M 436M 5 062M 3 630M
depreciationAndAmortization 745M 748M 2 861M 675M 662M 2 647M 649M 672M 672M 2 697M 679M 671M 2 707M 2 702M
deferredIncomeTax -7M 167M -316M -31M 88M -508M -214M -36M 919M -226M 14M -74M -604M -422M
stockBasedCompensation 182M 86M 429M 159M 83M 393M 84M 146M 73M 355M 81M 137M 359M 344M
changeInWorkingCapital -1 422M -1 147M -1 054M 905M -905M -484M 510M -1 095M -823M -967M -475M -301M -889M -701M
accountsReceivables -214M 288M -433M -291M 110M -391M -23M -281M 164M -576M -62M -435M -477M -761M
inventory -299M -373M -292M -61M -217M -139M 86M -206M -410M -939M -152M -404M -560M 78M
accountsPayables -182M -598M 209M -103M -604M 391M 446M -26M -673M 696M 0 0 213M 531M
otherWorkingCapital -727M -464M -538M 1 360M -194M -345M 1 000 000 -582M 96M -148M -261M 538M -65M -549M
otherNonCashItems 53M 187M 433M -2 028M 16M 1 063M 123M 63M -763M 396M 47M 53M 711M 687M
netCashProvidedByOperatingActivities 925M 1 088M 7 044M 958M 986M 6 787M 2 474M 661M 875M 6 039M 1 574M 922M 7 346M 6 240M
investmentsInPropertyPlantAndEquipment -468M -504M -1 859M -404M -520M -1 587M -346M -461M -354M -1 459M -332M -323M -1 368M -1 355M
acquisitionsNet 0 0 -98M 0 0 -211M -52M -22M 0 -1 867M -1 191M -676M -91M -994M
purchasesOfInvestments -2 101M -2 100M -8 226M -2 140M -1 879M -7 748M -2 019M -1 487M -1 916M -7 514M -1 729M -1 859M -9 882M -11 808M
salesMaturitiesOfInvestments 1 948M 2 010M 8 495M 2 181M 2 157M 7 441M 1 806M 1 588M 1 748M 7 343M 1 778M 1 723M 9 692M 11 345M
otherInvestingActivites 139M -125M 18M -17M -96M -42M -17M 1 187M -11M
netCashUsedForInvestingActivites -482M -719M -345M -259M -707M -424M -539M -287M -1 146M
debtRepayment 732M -513M 557M 2 585M -311M -821M -500M -772M -772M
commonStockIssued 160M 95M 143M 89M 57M 72M 77M 56M 110M
commonStockRepurchased -372M -123M -3 235M -288M -2 492M -2 138M -132M -226M -152M -645M -71M -141M -2 544M -652M
dividendsPaid -910M -910M -897M -898M -917M -918M -918M -904M -904M
otherFinancingActivites -5M 70M -49M -15M -197M 1 803M 992M -443M 4 721M
netCashUsedProvidedByFinancingActivities -395M -1 381M -534M -731M -1 500M -90M -501M -2 134M 3 014M
effectOfForexChangesOnCash -1 321M -1 206M 188M 4M 31M -230M 44M -175M -39M 243M 540M -101M -230M 215M
netChangeInCash -1 273M -2 218M 934M 83M 27M -259M 312M -28M -204M -2 171M -307M 2 688M 121M -547M
cashAtEndOfPeriod 0 0 2 218M 1 394M 1 311M 1 284M 1 623M 1 311M 1 339M 1 543M 4 521M 4 828M 3 714M 3 593M
cashAtBeginningOfPeriod 1 273M 2 218M 1 284M 1 311M 1 284M 1 543M 1 311M 1 339M 1 543M 3 714M 4 828M 2 140M 3 593M 4 140M
operatingCashFlow 925M 1 088M 7 044M 958M 986M 6 787M 2 474M 661M 875M 6 039M 1 574M 922M 7 346M 6 240M
capitalExpenditure -468M -504M -1 859M -404M -520M -1 587M -346M -461M -354M -1 459M -332M -323M -1 368M -1 355M
freeCashFlow 457M 584M 5 185M 554M 466M 5 200M 2 128M 200M 521M 4 580M 1 242M 599M 5 978M 4 885M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-06-20 2024-06-20 2023-06-22 2022-06-23 2021-06-25
fiscalYear 2025 2024 2023 2022 2021
otherInvestingActivities -249M -261M 4M -10M -54M
netCashProvidedByInvestingActivities -1 937M -2 366M -3 493M -1 659M -2 866M
netDebtIssuance 2 139M 1 073M -598M -1 000 000 -570M
longTermNetDebtIssuance 2 139M 1 073M -603M -1 000 000 -195M
shortTermNetDebtIssuance 0 0 5M 0 -375M
netStockIssuance -2 727M -1 854M -645M -2 115M -652M
netCommonStockIssuance -2 727M -1 854M -337M -2 115M -178M
commonStockIssuance 508M 284M 308M 429M 474M
netPreferredStockIssuance 0 0 -308M 0 -474M
netDividendsPaid -3 589M -3 666M -3 616M -3 383M -3 120M
commonDividendsPaid -3 589M -3 666M -3 616M -3 383M -3 120M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -184M -3M -101M 163M 206M
netCashProvidedByFinancingActivities -4 361M -4 450M -4 960M -5 336M -4 136M
incomeTaxesPaid 1 819M 1 622M 1 548M 996M 1 250M
interestPaid 762M 826M 606M 540M 582M

Earning call transcript

2025 q3
2025-11-18 ET (fiscal 2026 q2)
2025 q2
2025-08-19 ET (fiscal 2026 q1)
2025 q1
2025-05-21 ET (fiscal 2025 q4)
2024 q4
2025-02-18 ET (fiscal 2025 q3)
2024 q3
2024-11-19 ET (fiscal 2025 q2)
2024 q2
2024-08-20 ET (fiscal 2025 q1)
2024 q1
2023-11-21 ET (fiscal 2024 q4)
2023 q4
2024-02-20 ET (fiscal 2024 q3)
2023 q3
2023-11-21 ET (fiscal 2024 q2)
2023 q2
2023-08-22 ET (fiscal 2024 q1)
2023 q1
2023-05-25 ET (fiscal 2023 q4)
2022 q4
2023-02-21 ET (fiscal 2023 q3)
2022 q3
2022-11-22 ET (fiscal 2023 q2)
2022 q2
2022-08-23 ET (fiscal 2023 q1)
2022 q1
2022-05-26 ET (fiscal 2022 q4)
2021 q4
2022-02-22 ET (fiscal 2022 q3)
2021 q3
2021-11-23 ET (fiscal 2022 q2)
2021 q2
2021-08-24 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-25 21:18 ET
Medtronic reported for 2025 q3
SEC form 8
2025-11-18 06:47 ET
Medtronic published news for 2025 q3
SEC form 8
2025-11-18 06:47 ET
Medtronic reported for 2025 q3
SEC form 8
2025-09-29 12:45 ET
Medtronic published news for 2025 q2
SEC form 8
2025-09-29 12:45 ET
Medtronic published news for 2025 q2
SEC form 8
2025-09-29 12:45 ET
Medtronic published news for 2025 q2
SEC form 8
2025-09-29 12:45 ET
Medtronic published news for 2025 q2
SEC form 8
2025-09-29 12:45 ET
Medtronic published news for 2025 q2
SEC form 8
2025-09-29 12:45 ET
Medtronic published news for 2025 q2
SEC form 8
2025-09-16 20:41 ET
Medtronic published news for 2025 q2
SEC form 8
2025-09-16 20:41 ET
Medtronic published news for 2025 q2
SEC form 10
2025-08-26 21:26 ET
Medtronic reported for 2025 q2
SEC form 8
2025-08-19 10:49 ET
Medtronic published news for 2025 q2
SEC form 8
2025-08-19 10:49 ET
Medtronic reported for 2025 q2
SEC form 8
2025-08-19 10:49 ET
Medtronic published news for 2025 q2
SEC form 10
2025-06-20 10:46 ET
Medtronic reported for 2025 q1
SEC form 8
2025-05-21 10:47 ET
Medtronic published news for 2025 q1
SEC form 8
2025-05-21 10:47 ET
Medtronic reported for 2025 q1
SEC form 8
2025-05-21 10:47 ET
Medtronic published news for 2025 q1
SEC form 10
2025-02-25 21:17 ET
Medtronic published news for 2024 q4
SEC form 10
2025-02-25 00:00 ET
Medtronic published news for 2024 q4
SEC form 8
2025-02-18 00:00 ET
Medtronic published news for 2024 q4
SEC form 8
2025-02-18 00:00 ET
Medtronic reported for 2024 q4
SEC form 10
2024-11-26 16:16 ET
Medtronic reported for 2024 q3
SEC form 10
2024-11-26 00:00 ET
Medtronic published news for 2024 q3
SEC form 8
2024-11-19 06:46 ET
Medtronic published news for 2024 q3
SEC form 8
2024-11-19 06:46 ET
Medtronic published news for 2024 q3
SEC form 10
2024-08-27 00:00 ET
Medtronic reported for 2024 q2
SEC form 8
2024-08-20 06:46 ET
Medtronic published news for 2024 q2
SEC form 8
2024-08-20 06:46 ET
Medtronic published news for 2024 q2
SEC form 10
2024-06-20 16:16 ET
Medtronic published news for 2024 q1
SEC form 10
2024-06-20 00:00 ET
Medtronic published news for 2024 q1
SEC form 8
2024-05-23 06:47 ET
Medtronic published news for 2024 q1
SEC form 8
2024-05-23 06:47 ET
Medtronic reported for 2024 q1
SEC form 10
2024-02-27 16:16 ET
Medtronic published news for 2023 q4
SEC form 10
2024-02-27 00:00 ET
Medtronic published news for 2023 q4
SEC form 8
2024-02-20 06:47 ET
Medtronic published news for 2023 q4
SEC form 8
2024-02-20 06:47 ET
Medtronic reported for 2023 q4
SEC form 10
2023-11-30 00:00 ET
Medtronic published news for 2023 q3
SEC form 8
2023-11-21 06:53 ET
Medtronic reported for 2023 q3
SEC form 10
2023-08-31 00:00 ET
Medtronic reported for 2023 q2
SEC form 6
2023-08-22 06:47 ET
Medtronic reported for 2023 q2
SEC form 8
2023-08-22 00:00 ET
Medtronic reported for 2023 q2
SEC form 6
2023-08-11 16:22 ET
Medtronic published news for 2023 q2
SEC form 6
2023-06-26 07:23 ET
Medtronic published news for 2023 q1
SEC form 10
2023-06-22 16:32 ET
Medtronic published news for 2023 q1
SEC form 10
2023-06-22 00:00 ET
Medtronic published news for 2023 q1
SEC form 6
2023-05-25 06:48 ET
Medtronic reported for 2023 q1
SEC form 8
2023-05-25 00:00 ET
Medtronic published news for 2023 q1
SEC form 6
2023-03-30 16:34 ET
Medtronic published news for 2022 q4
SEC form 6
2023-03-09 12:20 ET
Medtronic published news for 2022 q4
SEC form 6
2023-03-07 17:02 ET
Medtronic published news for 2022 q4
SEC form 10
2023-03-01 16:13 ET
Medtronic reported for 2022 q4
SEC form 10
2023-03-01 00:00 ET
Medtronic reported for 2022 q4
SEC form 6
2023-02-21 06:48 ET
Medtronic published news for 2022 q4
SEC form 8
2023-02-21 00:00 ET
Medtronic reported for 2022 q4
SEC form 6
2022-12-12 17:56 ET
Medtronic published news for 2022 q3
SEC form 10
2022-12-01 16:17 ET
Medtronic reported for 2022 q3
SEC form 10
2022-12-01 00:00 ET
Medtronic reported for 2022 q3
SEC form 6
2022-11-22 06:47 ET
Medtronic published news for 2022 q3
SEC form 8
2022-11-22 00:00 ET
Medtronic reported for 2022 q3
SEC form 6
2022-10-25 16:16 ET
Medtronic published news for 2022 q3
SEC form 6
2022-10-25 16:16 ET
Medtronic published news for 2022 q3
SEC form 6
2022-09-21 09:16 ET
Medtronic published news for 2022 q2
SEC form 10
2022-09-01 16:12 ET
Medtronic reported for 2022 q2
SEC form 10
2022-09-01 00:00 ET
Medtronic reported for 2022 q2
SEC form 6
2022-08-23 06:47 ET
Medtronic published news for 2022 q2
SEC form 8
2022-08-23 00:00 ET
Medtronic reported for 2022 q2
SEC form 6
2022-08-19 16:31 ET
Medtronic published news for 2022 q2
SEC form 6
2022-06-27 16:11 ET
Medtronic published news for 2022 q1
SEC form 10
2022-06-23 16:13 ET
Medtronic reported for 2022 q1
SEC form 10
2022-06-23 00:00 ET
Medtronic reported for 2022 q1
SEC form 6
2022-05-26 06:49 ET
Medtronic published news for 2022 q1
SEC form 8
2022-05-26 00:00 ET
Medtronic reported for 2022 q1
SEC form 6
2022-05-02 07:11 ET
Medtronic published news for 2022 q1
SEC form 10
2022-03-03 16:27 ET
Medtronic published news for 2021 q4
SEC form 10
2022-03-03 00:00 ET
Medtronic published news for 2021 q4
SEC form 6
2022-02-22 06:47 ET
Medtronic published news for 2021 q4
SEC form 8
2022-02-22 00:00 ET
Medtronic published news for 2021 q4
SEC form 6
2021-12-16 16:18 ET
Medtronic published news for 2021 q3
SEC form 6
2021-12-15 06:47 ET
Medtronic published news for 2021 q3
SEC form 6
2021-12-14 16:30 ET
Medtronic published news for 2021 q3
SEC form 10
2021-12-02 16:07 ET
Medtronic published news for 2021 q3
SEC form 10
2021-12-02 00:00 ET
Medtronic published news for 2021 q3
SEC form 6
2021-11-23 06:49 ET
Medtronic published news for 2021 q3
SEC form 8
2021-11-23 00:00 ET
Medtronic published news for 2021 q3
SEC form 6
2021-10-25 16:11 ET
Medtronic published news for 2021 q3
SEC form 6
2021-10-25 16:06 ET
Medtronic published news for 2021 q3
SEC form 6
2021-10-15 16:30 ET
Medtronic published news for 2021 q3
SEC form 6
2021-09-10 06:55 ET
Medtronic published news for 2021 q2
SEC form 10
2021-09-02 16:08 ET
Medtronic published news for 2021 q2
SEC form 10
2021-09-02 00:00 ET
Medtronic published news for 2021 q2
SEC form 6
2021-08-27 16:16 ET
Medtronic published news for 2021 q2
SEC form 6
2021-08-24 06:50 ET
Medtronic published news for 2021 q2
SEC form 8
2021-08-24 00:00 ET
Medtronic published news for 2021 q2
SEC form 6
2021-06-30 06:55 ET
Medtronic published news for 2021 q1
SEC form 6
2021-06-25 16:53 ET
Medtronic published news for 2021 q1
SEC form 10
2021-06-25 16:51 ET
Medtronic published news for 2021 q1
SEC form 10
2021-06-25 00:00 ET
Medtronic published news for 2021 q1
SEC form 6
2021-05-27 06:46 ET
Medtronic published news for 2021 q1
SEC form 8
2021-05-27 00:00 ET
Medtronic published news for 2021 q1
SEC form 6
2021-03-31 16:30 ET
Medtronic published news for 2020 q4
SEC form 10
2021-03-05 16:56 ET
Medtronic published news for 2020 q4
SEC form 6
2021-02-23 06:49 ET
Medtronic published news for 2020 q4
SEC form 6
2021-02-17 06:48 ET
Medtronic published news for 2020 q4
SEC form 6
2020-12-14 16:31 ET
Medtronic published news for 2020 q3
SEC form 10
2020-12-03 16:15 ET
Medtronic published news for 2020 q3
SEC form 6
2020-11-24 06:50 ET
Medtronic published news for 2020 q3
SEC form 6
2020-10-26 16:10 ET
Medtronic published news for 2020 q3
SEC form 6
2020-10-26 16:09 ET
Medtronic published news for 2020 q3
SEC form 6
2020-10-06 17:02 ET
Medtronic published news for 2020 q3
SEC form 6
2020-08-14 16:55 ET
Medtronic published news for 2020 q2